U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07332221) titled 'Application of Toripalimab as Adjuvant Therapy After Esophageal Cancer Surgery: A Multicenter Clinical Trial' on Dec. 29, 2025.
Brief Summary: This study is a prospective, multicenter, multi-cohort Phase III clinical trial. It primarily enrolls high-risk recurrent esophageal cancer patients who have undergone R0 resection after neoadjuvant chemoimmunotherapy. Eligible patients are stratified based on pathological lymph node status and receive either toripalimab monotherapy as maintenance treatment or clinical observation only.
Study Start Date: Jan. 20
Study Type: INTERVENTIONAL
Condition:
Esophageal Cancer
Intervention:
DRUG:...